ReSolute, which is described as a “flagship EU project focused on creating a new, sustainably-sourced, safer alternative to traditional, fossil-based solvents”, officially launched on 15 October. Engineering work on its planned 1,000 tonnes/year levoglucosenone (LGO) plant somewhere in Eastern Europe begins in November, with commissioning expected at the end of 2022.
Plant-based ingredients firm Roquette has announced that its first expertise centre in the field of cosmetics will start operating in November. The company said that this is “an important milestone in Roquette Beauté’s development strategy and willingness to be recognised as the B2B expert in plant-based ingredients for cosmetics for the years to come”.
US private equity giant Ardian has acquired a 50% stake in Angus Chemical from Golden Gate Capital at a total enterprise value of about $2.25 billion. Golden Gate, which bought the firm from Dow Chemical in February 2015, will retain the other. The deal should close at the end of the year.
Siegfried has agreed to buy two drug product sites near Barcelona, Spain, from Novartis, in a deal expected to close by the end of 2020. Terms were not disclosed but Siegfried said that its sales should surpass CHF 1 billion in 2021, with the drug product operations “achieving the targeted critical size”.
Pharmaceutical CDMO Sterling Pharma Solutions which is based near Newcastle-upon-Tyne, UK, and was formerly owned by Rhodia and Shasun, has acquired Alcami’s facility at Germantown, Wisconsin (pictured). Terms were not disclosed.
Sterling said that this will boost its API development and manufacturing capacity, particularly for complex and hazardous requirements, and including high potency. Germantown has cGMP development, scale-up and manufacturing facilities with specialist expertise in handling technologies including plant-scale hydrogenation and cryogenic reactions.
Brenntag, the world’s largest distributor of chemicals and ingredients, has unveiled a new two-division operating model under two COOs, which it will operate from January 2021. This is described as part of the ongoing ‘Project Brenntag’ transformation programme.
Umicore has announced plans to streamline its cobalt activities in the Cobalt & Specialty Materials business unit in order to strengthen its competitive position. This will lead to about €55 million in charges.
The unit, which makes cobalt and nickel speciality chemicals for a wide-range of non-battery applications, has been facing increasing competition in many markets and in cobalt refining in recent years.